| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.TRIM.2008.10.005 |
| P698 | PubMed publication ID | 18955143 |
| P50 | author | David K. C. Cooper | Q87755223 |
| P2093 | author name string | Bruno Gridelli | |
| Burcin Ekser | |||
| Paolo Rigotti | |||
| P2860 | cites work | alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months | Q28193880 |
| Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival | Q28213664 | ||
| Viable offspring derived from fetal and adult mammalian cells | Q28304072 | ||
| Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine | Q31047713 | ||
| Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation | Q33342998 | ||
| Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group | Q33871594 | ||
| Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations | Q33904933 | ||
| Cloned pigs produced by nuclear transfer from adult somatic cells | Q33918147 | ||
| Production of alpha 1,3-galactosyltransferase-deficient pigs | Q33963251 | ||
| Xenotransplantation of the liver | Q34170336 | ||
| Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection | Q34315275 | ||
| Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys | Q34480315 | ||
| A human CD46 transgenic pig model system for the study of discordant xenotransplantation | Q34513633 | ||
| Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors | Q34608583 | ||
| Animal transgenesis: state of the art and applications | Q34608788 | ||
| Xenotransplantation: infectious risk revisited | Q35861536 | ||
| Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection | Q35898992 | ||
| The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation. | Q36183720 | ||
| Pigs taking wing with transposons and recombinases. | Q36187528 | ||
| Carbohydrates in xenotransplantation. | Q36201681 | ||
| Pathology of renal xenograft rejection in pig to non-human primate transplantation | Q36539624 | ||
| Selected physiologic compatibilities and incompatibilities between human and porcine organ systems | Q36632325 | ||
| Progress in xenotransplantation following the introduction of gene-knockout technology | Q36713339 | ||
| Pig-to-non-human primate heart transplantation: immunologic progress over 20 years | Q36754966 | ||
| Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here? | Q36878996 | ||
| An update on xenotransplantation | Q36903599 | ||
| Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine | Q36954781 | ||
| Reappraisal of biosafety risks posed by PERVs in xenotransplantation | Q36995344 | ||
| Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunologic barriers | Q37126193 | ||
| Xenotransplantation: where are we in 2008? | Q37140607 | ||
| Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes | Q79532880 | ||
| Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig-to-baboon xenotransplantation | Q80020967 | ||
| Antibodies directed to pig non-Gal antigens in naïve and sensitized baboons | Q80152150 | ||
| The pig-to-primate immune response: relevance for xenotransplantation | Q80298006 | ||
| Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons | Q80435544 | ||
| Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience | Q81199195 | ||
| Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants | Q81238227 | ||
| The coagulation barrier in xenotransplantation: incompatibilities and strategies to overcome them. | Q37236863 | ||
| Shear-induced platelet aggregation | Q37582206 | ||
| Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. | Q38288887 | ||
| Evaluation of different alpha-Galactosyl glycoconjugates for use in xenotransplantation | Q38289265 | ||
| Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans | Q38312428 | ||
| Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine | Q39321537 | ||
| Discordant organ xenotransplantation in primates: world experience and current status | Q40841815 | ||
| Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. | Q42275309 | ||
| Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. | Q42820266 | ||
| C1-Inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys | Q43818418 | ||
| The alpha-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts | Q43828706 | ||
| Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation | Q43940368 | ||
| Assessment of renal function during the postoperative period following liver xenotransplantation from transgenic pig to baboon. | Q43963140 | ||
| Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood | Q43974590 | ||
| Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets | Q44139530 | ||
| Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. | Q44304002 | ||
| Pig-to-baboon liver xenografts | Q44852598 | ||
| Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. | Q45171019 | ||
| Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue | Q45201952 | ||
| Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model | Q45252437 | ||
| Cardiac xenotransplantation: recent preclinical progress with 3-month median survival | Q46695733 | ||
| Recent advances in pig-to-human organ and cell transplantation | Q46849311 | ||
| The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy | Q46911711 | ||
| Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion | Q47418935 | ||
| Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors | Q47842680 | ||
| Orthotopic heart transplantation in a transgenic pig-to-primate model. | Q47842697 | ||
| Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation. | Q51038598 | ||
| Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. | Q52919756 | ||
| Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. | Q53664360 | ||
| Prevention of Hyperacute Rejection in a Model of Orthotopic Liver Xenotransplantation From Pig to Baboon Using Polytransgenic Pig Livers (CD55, CD59, and H-Transferase) | Q57583770 | ||
| Genetically engineered pigs | Q72230307 | ||
| Mechanisms of resistance to injury in pig livers perfused with blood from patients in liver failure | Q73279753 | ||
| Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness | Q73459820 | ||
| Life supporting function for over one month of a transgenic porcine heart in a baboon | Q73513215 | ||
| The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation | Q73810362 | ||
| Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy | Q73884179 | ||
| HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood | Q74070801 | ||
| Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation | Q74350187 | ||
| Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate | Q74365695 | ||
| Physiological aspects of pig-to-primate renal xenotransplantation | Q74566890 | ||
| Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts | Q74604864 | ||
| Three-month survival of HDAFF transgenic pig hearts transplanted into primates | Q74616950 | ||
| Anti-CD154 monoclonal antibody and thromboembolism revisted | Q74622610 | ||
| Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons | Q77370557 | ||
| Complement activation in discordant hepatic xenotransplantation | Q77895161 | ||
| Extended coagulation profiles of healthy baboons and of baboons rejecting GT-KO pig heart grafts | Q79293143 | ||
| P433 | issue | 2 | |
| P921 | main subject | pig | Q787 |
| primate | Q7380 | ||
| P304 | page(s) | 87-92 | |
| P577 | publication date | 2008-10-26 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Xenotransplantation of solid organs in the pig-to-primate model | |
| P478 | volume | 21 |
| Q34903423 | Alternative immunomodulatory strategies for xenotransplantation: CD80/CD86-CTLA4 pathway-modified immature dendritic cells promote xenograft survival |
| Q39862341 | Attitude toward xenotransplantation of patients prior and after human organ transplantation |
| Q64068228 | CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation |
| Q34678508 | Cell replication in craniofacial periosteum: appositional vs. resorptive sites |
| Q26823663 | Clinical lung xenotransplantation--what donor genetic modifications may be necessary? |
| Q45795426 | Clinicopathological findings in non-human primate recipients of porcine renal xenografts: quantitative and qualitative evaluation of proteinuria |
| Q36152568 | Cloning of porcine platelet glycoprotein Ibα and comparison with the human homolog |
| Q33394275 | Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants |
| Q33872613 | Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome. |
| Q36442981 | Comparison of hematologic, biochemical, and coagulation parameters in α1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species |
| Q36386394 | Current status of pig heart xenotransplantation |
| Q34666113 | Deciphering modifications in swine cardiac troponin I by top-down high-resolution tandem mass spectrometry |
| Q50537582 | Design of a real-time quantitative polymerase chain reaction to assess human complement regulatory protein gene expression in polytransgenic xenograft pigs. |
| Q90220069 | Different gut microbiome composition in obese Guizhou minipigs between female and castrated male |
| Q57583567 | Donor-Graft Compatibility Tests in Pig-to-Primate Xenotransplantation Model: Serum Versus Plasma in Real-Time Cell Analyzer Trials |
| Q34185181 | Double transgenic pigs with combined expression of human α1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection |
| Q64912727 | Effects of manganese on maturation of porcine oocytes in vitro and their subsequent embryo development after parthenogenetic activation and somatic cell nuclear transfer. |
| Q37951013 | Exploiting nature's rich source of proteasome inhibitors as starting points in drug development |
| Q83568737 | Expression of human CD46 has no effect on porcine circovirus type 2 infection and shedding in the experimental pig model |
| Q35235968 | Future of liver transplantation: non-human primates for patient-specific organs from induced pluripotent stem cells |
| Q38184413 | Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration. |
| Q28543038 | Gene expression and pathway analysis of effects of the CMAH deactivation on mouse lung, kidney and heart |
| Q46312048 | Generation of human-to-pig chimerism to induce tolerance through transcutaneous in utero injection of cord blood-derived mononuclear cells or human bone marrow mesenchymals cells in a preclinical program of liver xenotransplantation: preliminary res |
| Q37815273 | Genetic modification of pigs for solid organ xenotransplantation. |
| Q37997627 | Genetically modified pigs for biomedical research. |
| Q43503268 | Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status |
| Q34230956 | Identification of human preformed antibody targets in GTKO pigs |
| Q34037106 | Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue |
| Q64888449 | Improvement of in vitro and early in utero porcine clone development after somatic donor cells are cultured under hypoxia. |
| Q33417115 | Increased transfusion-free survival following auxiliary pig liver xenotransplantation |
| Q57072767 | Isolation and Characterization of Multipotent CD24+ Cells From the Renal Papilla of Swine |
| Q51550288 | Long-term high intake of whole proteins results in renal damage in pigs. |
| Q38231495 | Lung xenotransplantation: recent progress and current status |
| Q28536938 | Mechanism of porcine liver xanthine oxidoreductase mediated N-oxide reduction of cyadox as revealed by docking and mutagenesis studies |
| Q52424840 | Modified glycan models of pig-to-human xenotransplantation do not enhance the human-anti-pig T cell response. |
| Q38408530 | Normothermic liver preservation: a new paradigm? |
| Q44261160 | Nucleofection-mediated α1,3-galactosyltransferase gene inactivation and membrane cofactor protein expression for pig-to-primate xenotransplantation |
| Q83842594 | On the road to clinical xenotransplantation |
| Q50875817 | Outcomes of alpha 1,3-GT-knockout porcine heart transplants into a preclinical nonhuman primate model. |
| Q37424698 | Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? |
| Q47136558 | Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate? |
| Q34737368 | Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genes |
| Q37828115 | Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies |
| Q41723730 | Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model |
| Q39742342 | Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going? |
| Q37547263 | Structural biology of carbohydrate xenoantigens |
| Q33719470 | Suboptimal Porcine Endogenous Retrovirus Infection in Non-Human Primate Cells: Implication for Preclinical Xenotransplantation |
| Q53646009 | Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G. |
| Q37375594 | Systems biology approach to the dissection of the complexity of regulatory networks in the S. scrofa cardiocirculatory system |
| Q41846160 | T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons. |
| Q53307569 | The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of Formosan macaques. |
| Q38013049 | The role of complement in the early immune response to transplantation. |
| Q37854406 | Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates. |
| Q31155408 | Tissue-specific expression and regulatory networks of pig microRNAome |
| Q58287953 | Up-regulation of fibrinogen-like protein 2 in porcine endothelial cells by xenogeneic CD40 signal |
| Q42849566 | Validation of xCELLigence real-time cell analyzer to assess compatibility in xenotransplantation with pig-to-baboon model. |
| Q37870981 | Xenotransplantation: from the lab to the clinic: Sunrise Symposium at the XXIII International Congress of the Transplantation Society, Vancouver, Canada, August 2010. |
Search more.